| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.059 | 0.5 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |